Search for: "In re: M.D" Results 1161 - 1180 of 1,269
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Mar 2016, 3:16 pm by Schachtman
No. 55 in In re Lipitor Marketing, Sales Practices and Products Liability Litigation) [cited as Hempstead]. [read post]
18 Sep 2015, 7:30 am by Jim Sedor
“These are deep, kind of human psychological traits that you’re probably not going to change. [read post]
10 Mar 2011, 2:20 pm by Law Lady
SMITH AND MARIE LAUGHLIN, Appellees. 5th District.Bankruptcy -- Fraudulent transfers -- Avoidance -- Chapter 11 trustee filed complaint to avoid as actual fraudulent transfers the total amount of loan repayments made to bank from debtors within past four years, alleging that debtor and his co-debtor companies perpetrated bank fraud scheme in which debtors falsified due diligence materials to con banks into lending debtor and his co-debtor companies millions of dollars -- Bank is not entitled to… [read post]
6 Jun 2007, 10:34 am
And the undisputed evidence shows that the District has classified all apartment complexes as residential users under Res. 02-02. [read post]
22 Nov 2018, 9:00 am by Michael H Cohen
If you’re not authorized to provide medical care, you need to direct the patient to someone who does have that authority. [read post]
19 Feb 2021, 11:47 am by admin
Shubin only because of the “Harry Shubin, M.D. [read post]
13 Dec 2008, 10:03 am
Finding his sentence procedurally and substantively reasonable, we affirm 08b0021p.06  In re: Ronald Anderson v. [read post]
18 Nov 2021, 1:03 pm by Eugene Volokh
" Moreover, without a party's name in the public record, "it is difficult to apply legal principles of res judicata and collateral estoppel. [read post]
25 Jun 2012, 8:43 am by Max Kennerly, Esq.
So, you’re a plaintiff’s lawyer, and a client (or their survivor) has just come in after a tasing incident. [read post]
12 Jun 2023, 1:09 pm by admin
In scientific publishing, when scientists make a mistake, they publish an erratum or a corrigendum. [read post]
15 Apr 2009, 4:44 am
Astrazenaca Pharmaceuticals, LP, 223 F.R.D. 659, 663-64 (M.D. [read post]
23 Jan 2020, 10:37 pm by Schachtman
The phosphodiesterases 5 inhibitor medications (PDE5i) seem to arouse the litigation propensities of the lawsuit industry. [read post]